COMMUNIQUÉS West-GlobeNewswire

Zosano Pharma Reports First Quarter 2018 Financial Results and Operational Update

15/05/2018 - 22:00

Completion of follow on offering netting $45.7 million Issuance of new US patent Long-term safety study now has 250 subjects enrolled FREMONT, Calif., May 15, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ: [...]

GrowForce picks Winnipeg for flagship cannabis facility

15/05/2018 - 20:44

New 120,000 sq. ft. cannabis cultivation operation will open in 2019 WINNIPEG, Manitoba, May 15, 2018 (GLOBE NEWSWIRE) -- GrowForce Holdings Inc., a new Canadian cannabis company, announced today it will open its [...]

BIOPHYTIS Receives Orphan Drug Designation in the United States for Sarconeos in Duchenne Muscular Dystrophy (DMD)

15/05/2018 - 20:22

PARIS, May 15, 2018 (GLOBE NEWSWIRE) -- BIOPHYTIS (Euronext Growth Paris:ALBPS), a biotechnology company specializing in the development of drug candidates to treat age-related degenerative diseases, announces that the [...]

Las Vegas Cosmetic Surgery Practice Welcomes New Plastic Surgeon

15/05/2018 - 20:15

Rohit Jaiswal, MD joins W. Tracy Hankins, MD and Samuel M. Sohn, MD at their state-of-the-art plastic surgery practice with locations in Las Vegas and Henderson; The cosmetic surgeon brings with him skill in breast [...]

Leading-edge Scientists in Innate Immunity Join Qu Biologics’ Scientific Advisory Board

15/05/2018 - 19:34

VANCOUVER, British Columbia, May 15, 2018 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore [...]

RadNet, Inc. to Present at the Bank of America Merrill Lynch 2018 Health Care Conference on May 17th, 2018

15/05/2018 - 19:13

LOS ANGELES, May 15, 2018 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated [...]

Nohla Therapeutics Announces Closing of $45 Million Series B Financing

15/05/2018 - 19:00

Proceeds to Support the Development of Dilanubicel (NLA101) and Additional Platform Programs SEATTLE, May 15, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics, a leading developer of universal, off-the-shelf cell therapies [...]

Capital Increase in Genmab as a Result of Employee Warrant Exercise

15/05/2018 - 18:49

Company Announcement Copenhagen, Denmark; May 15, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 155,576 shares as a consequence of the exercise of employee warrants. The increase is [...]

UPDATE -- Savara to Present at Bank of America Merrill Lynch 2018 Healthcare Conference on May 15th

15/05/2018 - 18:26

AUSTIN, Texas, May 15, 2018 (GLOBE NEWSWIRE) -- Savara Inc. (NASDAQ: SVRA ), an orphan lung disease company, announced today that the Company's Chief Executive Officer, Rob Neville, will present at the Bank of America [...]

INSYS Therapeutics Responds to Unsealing of Previously Filed Qui Tam Complaints and Recaps Transformation Efforts

15/05/2018 - 18:23

PHOENIX, May 15, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today issued the [...]

90TH VIFOR PHARMA GROUP ANNUAL SHAREHOLDER MEETING

15/05/2018 - 18:21

All proposals of the Board of Directors approved by shareholders Election of Jacques Theurillat to the Board of Directors Re-election of standing members of the Board of Directors Dividend of CHF 2.00 approved AT THE 90 [...]

NEOVACS STRENGTHENS INTELLECTUAL PROPERTY POSITION IN EUROPE AND JAPAN

15/05/2018 - 18:06

PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS STRENGTHENS INTELLECTUAL PROPERTY POSITION IN EUROPE AND JAPAN Newly issued patent covers IFNalpha Kinoid and its application in all diseases related to an [...]

NÉOVACS RENFORCE SA PROPRIÉTÉ INTELLECTUELLE EN EUROPE ET AU JAPON

15/05/2018 - 18:06

COMMUNIQUÉ DE PRESSE NEOVACS RENFORCE SA PROPRI É T É INTELLECTUELLE EN EUROPE ET AU JAPON Ce brevet porte sur l'IFNalpha Kinoïde et son utilisation dans les maladies liées à la surproduction de la cytokine IFNalpha [...]

Annual General Meeting of Infant Bacterial Therapeutics AB

15/05/2018 - 18:00

The Annual General Meeting of Infant Bacterial Therapeutics AB (publ) on May 15, 2018 voted to approve the following resolutions: Adoption of the annual report Discharge from liability granted for the Board members and [...]

Intrommune Therapeutics Submits Pre-IND Meeting Request to the U.S. FDA for INT301, Its Peanut Allergy Oral Mucosal Immunotherapy Drug Candidate, During Food Allergy Awareness Week

15/05/2018 - 18:00

New York, May 15, 2018 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a NYC-based biopharmaceutical company developing a patient-friendly immunotherapy platform for the treatment of food allergies, submitted its request [...]

Virbac: Availability of the quarterly financial information as of March 31, 2018

15/05/2018 - 17:46

Virbac: Availability of the quarterly financial information as of March 31, 2018 Public release - May 15, 2018 The quarterly financial information as of March 31, 2018 is available: · on our website: corporate.virbac. [...]

Virbac : Mise à disposition de l'information financière trimestrielle au 31 mars 2018

15/05/2018 - 17:46

Virbac : Mise à disposition de l'information financière trimestrielle au 31 mars 2018 Communiqué diffusé le 15 mai 2018 L'information financière trimestrielle au 31 mars 2018 est disponible : · sur notre site internet [...]

Lysogene Announces the Nomination of Dr. Ralph Laufer as Chief Scientific Officer and Member of the Executive Team

15/05/2018 - 17:45

CAMBRIDGE, Mass. and PARIS, May 15, 2018 (GLOBE NEWSWIRE) -- Lysogene (FR0013233475 – LYS), a pioneering biopharmaceutical company specializing in gene therapy targeting central nervous system (CNS) diseases, is pleased [...]

90TH VIFOR PHARMA GROUP ANNUAL SHAREHOLDER MEETING

15/05/2018 - 17:35

All proposals of the Board of Directors approved by shareholders Election of Jacques Theurillat to the Board of Directors Re-election of standing members of the Board of Directors Dividend of CHF 2.00 approved AT THE 90 [...]